Cheniere Energy Inc. (0HWH)
London Exchange · UK · prices in USD · close of 19 Oct 2026
Key indicators
| Last close | USD 285.10 |
|---|---|
| 52-week range | 185.24 – 323.59 |
| Return, 1 month / 3 months | +5.6% / +8.7% |
| Return, 1 year / 3 years | +26.0% / +81.2% |
| Trend | Uptrend |
| RSI (14) | 58 |
| Volatility (1 year) | 29.3% |
| Worst drawdown (1 year) | -23.6% |
| Average daily value traded | 0.42M USD |
| Dividend yield | 0.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Cheniere Energy is an energy company based in Houston, Texas, that produces and exports liquefied natural gas. It operates large liquefaction facilities on the Gulf Coast, where natural gas is cooled and loaded onto ships for delivery to customers around the world. Its customers include utilities, energy traders and industrial users in Europe, Asia and other regions. The company also owns regasification infrastructure and markets LNG under long-term contracts.
On this site Cheniere Energy Inc. appears as a stock on the London Exchange (UK), code 0HWH, with prices in US dollars (USD). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Cheniere Energy Inc. (0HWH) trades on the London Exchange in UK. It last closed at USD 285.10 on 19 October 2026.
Its price-based Market X-Ray is 68 out of 100 (a fair price profile), ranking 703 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 26.0% and over the last three months it rose 8.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 82 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 13.9% | ||
| From 52-week high | -3.3% | ||
| Momentum | 73 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 8.7% | ||
| 6-month return | 13.8% | ||
| 12-month return, skipping the last month | 19.3% | ||
| Stability (higher is calmer) | 64 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 29.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -23.6% | ||
| Liquidity | 44 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.42M USD | ||
| Zero-volume days | 0.0% | ||
| Income | 64 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 0.8% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +0.6% |
|---|---|
| 1 month | +5.6% |
| 3 months | +8.7% |
| 6 months | +13.8% |
| 1 year | +26.0% |
| 3 years | +81.2% |
| 5 years | – |
Signals
| 50-day / 200-day average | 277.10 / 250.41 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 8.79 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 7 Aug 2026 | USD 0.5550 |
| 8 May 2026 | USD 0.5550 |
| 5 Feb 2026 | USD 0.5550 |
| 6 Nov 2025 | USD 0.5550 |
| 7 Aug 2025 | USD 0.5000 |
| 8 May 2025 | USD 0.5000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.